Skip to content

Respiratory Syncytial Virus Antigen BA113VS

$851.00

Summary

  • Virion/Serion Immunologics Antigen for research use (RUO)
  • Respiratory Syncytial Virus Antigen, recombinant
  • Suitable for detection of IgA, IgG & IgM antibodies in ELISA
  • Lot specific concentration, specified in mg/mL
  • 1 mg

Order now and receive on May 30, 2024

Calculate shipping price

Please fill in the fields below with the shipping destination details in order to calculate the shipping cost.

Weight1 lbs
Dimensions9 × 5 × 2 in
target

Respiratory Syncytial Virus

species reactivity

Respiratory Syncytial Virus

applications

ELISA

assay type

Indirect & quantitative

available size

1 mg

kit
Research area
Infectious Disease
Storage
Store at -65°C or lower. Avoid repeated freeze-thaw cycles. Sonicate before use. 10 years from date of manufacture (under recommended storage conditions).
Form
liquid
Associated products
Respiratory Syncytial Virus Antigen (BA113VS)
Respiratory Syncytial Virus IgA Control Serum (BC113A)
Respiratory Syncytial Virus IgG Control Serum (BC113G)
Respiratory Syncytial Virus IgA ELISA Kit (ESR113A)
Respiratory Syncytial Virus IgG ELISA Kit (ESR113G)
Respiratory Syncytial Virus IgM ELISA Kit (ESR113M)
target relevance
Organism
Respiratory Syncytial Virus
Structure and strains
Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.
Disease
Human Respiratory Syncytial Viruses (RSV) are enveloped (-)ssRNA viruses belonging to the Paramyxoviridae family. The two subtypes, classified as A and B, are globally distributed and are primarily differentiated by the antigenic structures. Respiratory Syncytial Viruses cause diseases of the upper and lower respiratory tract, particularly in infants and the elderly.

Respiratory Syncytial Viruses are among the most important agents causing nosocomial respiratory diseases in infants, particular premature babies, immune compromised patients and the elderly. They elicit damage to the ciliated epithelium of the respiratory tract, which can be accompanied by the formation of syncytia. The following immune reaction may result in cell detritus which can block the bronchi and lead to respiratory distress. Epidemiological studies document that almost all children at the age of two years have been exposed to the virus. Diagnosis Antigen and antibody detection methods are important in the diagnosis of RSV infec
Detection and diagnosis
Antigen and antibody detection methods are important in the diagnosis of RSV infections. In serology, ELISA tests, which allow for the differentiation of IgA, IgG and IgM immunoglobulin classes, are of increasing importance.

Data

Publications

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

pmidtitleauthorscitation

Protocols

relevant to this product
BA113VS protocol

Documents

Product data sheet
BA113VS

Reviews

There are no reviews yet.

Be the first to review “Respiratory Syncytial Virus Antigen BA113VS”